Cargando…
Therapeutic Targeting of Histone Deacetylation to Prevent Alzheimer’s Disease
Efforts to find disease-modifying treatments for Alzheimer’s disease (AD) have been largely unsuccessful. The relative lack of progress and the age-related incidence of AD suggest that modulation of aging per se may be a useful alternative treatment approach. Therapeutics aimed at preventing or reve...
Autores principales: | Chacko, Sophia, Ladiges, Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385167/ https://www.ncbi.nlm.nih.gov/pubmed/35984647 |
Ejemplares similares
-
Understanding histone deacetylation in Huntington’s disease
por: Valor, Luis Miguel
Publicado: (2016) -
Histone deacetylation - a new epigenetic target in cancer
por: Carvalho, João A, et al.
Publicado: (2010) -
Histone deacetylation: Establishing a meiotic histone code
por: De La Fuente, Rabindranath
Publicado: (2014) -
Histone acetylation and deacetylation in ischemic stroke
por: Uzdensky, Anatoly B., et al.
Publicado: (2021) -
Targeting IGF1R signaling for brain aging and Alzheimer’s disease
por: Park, Joo Young, et al.
Publicado: (2022)